English Korean Chinese
ホーム > 市場調査レポート > 医薬品 > 米国における分子診断市場
カテゴリ
医薬品 (4962)
OTC (153)
がん (943)
ドラッグデリバリー (185)
ワクチン (181)
感染症 (353)
規制環境 (132)
後発医薬品 (135)
骨疾患 (37)
処方薬 (158)
神経疾患 (174)
精神疾患 (89)
製薬企業関連 (531)
創薬 (1523)
糖尿病 (192)
動物用医薬 (17)
肥満症 (44)
市場調査レポート

米国における分子診断市場

U.S. Molecular Diagnostics Markets

発行 Frost & Sullivan
出版日 2006年11月 商品コード 47413
ページ情報 英文 107 Pages
価格
US$ 6,000 換算 ¥ 482,820 (税抜) Web Access (Regional License)
US$ 6,500 換算 ¥ 523,055 (税抜) Hard Copy & Web Access (Regional License)


原文目次

Abstract

This research service provides market intelligence, analysis, and forecasts for the U.S. molecular diagnostics markets. The products discussed in this research service are in vitro diagnostic kits, consumables, and instruments.

A detailed analysis is provided with regard to these products and the companies that manufacture and distribute them. The forecast period is 2006 through 2012 with 2005 as the base year.

Table of Contents

1. EXECUTIVE SUMMARY

Executive Summary

  • 1. Executive Summary

2. TOTAL U.S. MOLECULAR DIAGNOSTICS MARKET

Market Overview

  • 1. Introduction
  • 2. Research Methodology
  • 3. Analysis

Revenue Forecasts

  • 1. Scope and Segmentation
  • 2. Market Forecasts

Total Market Forces and Trends

  • 1. Market Drivers
  • 2. Market Restraints
  • 3. Challenges and Strategic Recommendations
  • 4. Market and Technology Trends

3. U.S. MOLECULAR CLINICAL DIAGNOSTICS MARKET

Overview

  • 1. Introduction
  • 2. Measurements

Market Forecasts

  • 1. Scope and Segmentation
  • 2. Revenue Forecasts
  • 3. Market Share by Revenue and Testing Volumes

Competitive Analysis

  • 1. Competitive Landscape
  • 2. Company Market Share Analysis
  • 3. Product Analysis

4. U.S. MOLECULAR BLOOD SCREENING MARKET

Overview

  • 1. Introduction
  • 2. Measurements

Market Forecasts and Product Analysis

  • 1. Scope and Segmentation
  • 2. Revenue Forecasts

Competitive Analysis

  • 1. Competitive Landscape
  • 2. Company Market Share Analysis
  • 3. Product Analysis

5. APPENDIX

Decision Support Database

  • 1. Government Healthcare Expenditure
Back to Top